Indivior Pharmaceuticals, Inc. INDV Total debt
Total debt at other companies
Other financials
Where this comes from
Calculated from Indivior Pharmaceuticals, Inc. ’s reported figures.
Plus components not separately reported this period.
The official record: Indivior Pharmaceuticals, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Indivior Pharmaceuticals, Inc. 's total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Indivior Pharmaceuticals, Inc. 's total debt?
- Indivior Pharmaceuticals, Inc. (INDV) reported total debt of $509M in Q1 2026.
- How has Indivior Pharmaceuticals, Inc. 's total debt changed year-over-year?
- Indivior Pharmaceuticals, Inc. 's total debt increased by 37.6% year-over-year, from $370M to $509M.
- What is the long-term trend for Indivior Pharmaceuticals, Inc. 's total debt?
- Over 2 years (2023 to 2025), Indivior Pharmaceuticals, Inc. 's total debt has grown at a 11.4% compound annual growth rate (CAGR), from $283M to $351M.
- What does total debt mean?
- Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.